Androgens inhibit the stimulatory action of 17β-estradiol on normal human breast tissue in explant cultures

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages

  Eigeliene, Natalija ^a,b   Elo, Teresa ^a   Linhala, Mari ^a   Hurme, Saija ^a   Erkkola, Risto ^b   Har̈könen, Pirkko ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA HYDROXY 3 OXO 4 ANDROSTENE; AMPHIREGULIN; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; APOLIPOPROTEIN D; BICALUTAMIDE; CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; STEROID RECEPTOR; TESTOSTERONE; TREFOIL FACTOR 1; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST; BREAST EPITHELIUM; BREAST RECONSTRUCTION; CELL COUNT; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPLANT; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE CULTURE;

ANDROGENS; BREAST; CELLS, CULTURED; DIHYDROTESTOSTERONE; DOWN-REGULATION; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; ESTRADIOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MAMMAPLASTY; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PRIMARY CELL CULTURE; TESTOSTERONE;

LOTUS;

EID: 84863597131     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3228     Document Type: Article

References (41)

1. Labrie F 2006 Dehydroepiandrosterone, androgens and the mammary gland. Gynecol Endocrinol 22:118-130 (Pubitemid 43995028)
2. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH 2010 Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 95:s1-s66
3. Dimitrakakis C 2011 Androgens and breast cancer in men and women. Endocrinol Metab Clin North Am 40:533-547, viii
4. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE 2004 Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856-1865 (Pubitemid 40081323)
5. Hackenberg R, Hofmann J, Hölzel F, Schulz KD 1988 Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. J Cancer Res Clin Oncol 114:593-601 (Pubitemid 19011676)
6. Dimitrakakis C, Zhou J, Wang J, Belanger A, LaBrie F, Cheng C, Powell D, Bondy C 2003 A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 10:292-298 (Pubitemid 36870501)
7. Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW, Lee KS 2011 Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol 22:1755-1762
8. Macedo LF, Guo Z, Tilghman SL, Sabnis GJ, Qiu Y, Brodie A 2006 Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole. Cancer Res 66:7775-7782 (Pubitemid 44289238)
9. Shufelt CL, Braunstein GD 2008 Testosterone and the breast. Menopause Int 14:117-122
10. Somboonporn W, Davis SR 2004 Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25:374-388 (Pubitemid 38780666)
11. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K, Bondy CA 2000 Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 14:1725-1730
12. Slagter MH, Scorilas A, Gooren LJ, de Ronde W, Soosaipillai A, Giltay EJ, Paliouras M, Diamandis EP 2006 Effect of testosterone administration on serum and urine kallikrein concentrations in female- to-male transsexuals. Clin Chem 52:1546-1551 (Pubitemid 44148318)
13. Eigeliene N, Härkönen P, Erkkola R 2006 Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures.BMCCancer 6:246
14. Harding C, Osundeko O, Tetlow L, Faragher EB, Howell A, Bundred NJ 2000 Hormonally regulated proteins in breast secretions are markers of target organ sensitivity. Br J Cancer 82:354-360 (Pubitemid 30045381)
15. Blance RN, Sims AH, Anderson E, Howell A, Clarke RB 2009 Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogen. Cancer Prev Res (Phila) 2:257-264
16. Ciarloni L, Mallepell S, Brisken C 2007 Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci USA 104:5455-5460 (Pubitemid 47175701)
17. Bossard C, Jarry A, Colombeix C, Bach-Ngohou K, Moreau A, Loussouarn D, Mosnier JF, Laboisse CL 2006 Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index. J Clin Pathol 59:706-710 (Pubitemid 44048778)
18. Wilson CL, Sims AH, Howell A, Miller CJ, Clarke RB 2006 Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer 13:617-628 (Pubitemid 43886681)
19. Olsson AY, Bjartell A, Lilja H, Lundwall A 2005 Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues. Int J Cancer 113:290-297 (Pubitemid 39628320)
20. Black MH, Magklara A, Obiezu C, Levesque MA, Sutherland DJ, Tindall DJ, Young CY, Sauter ER, Diamandis EP 2000 Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. Br J Cancer 82:361-367 (Pubitemid 30045382)
21. Bhattacharyya RS, Krishnan AV, Swami S, Feldman D 2006 Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells. Mol Cancer Ther 5:1539-1549 (Pubitemid 44070491)
22. Hammes SR, Levin ER 2011 Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 152:4489-4495
23. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE 1990 Increased cell division as a cause of human cancer. Cancer Res 50:7415-7421
24. Dimitrakakis C, Zhou J, Bondy CA 2002 Androgens and mammary growth and neoplasia. Fertil Steril 77(Suppl 4):S26-S33 (Pubitemid 34465841)
25. Dimitrakakis C, Bondy C 2009 Androgens and the breast. Breast Cancer Res 11:212
26. Marugo M, Bernasconi D, Miglietta L, Fazzuoli L, Ravera F, Cassulo S, Giordano G 1992 Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T). J Steroid Biochem Mol Biol 42:547-554
27. Somboonporn W, Davis SR 2004 Postmenopausal testosterone therapy and breast cancer risk. Maturitas 49:267-275 (Pubitemid 39505180)
28. Poulin R, Baker D, Labrie F 1988 Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 12:213-225 (Pubitemid 19019103)
29. Hofling M, Hirschberg AL, Skoog L, Tani E, Hagerström T, von Schoultz B 2007 Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause 14:183-190 (Pubitemid 46673468)
30. Lanzino M, Sisci D, Morelli C, Garofalo C, Catalano S, Casaburi I, Capparelli C, Giordano C, Giordano F, Maggiolini M, Andò S Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells - identification of a novel androgen response element. Nucleic Acids Res 38:5351-5365
31. Comstock CE, Augello MA, Schiewer MJ, Karch J, Burd CJ, Ertel A, Knudsen ES, Jessen WJ, Aronow BJ, Knudsen KE 2011 Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. J Biol Chem 286:8117-8127
32. Kandouz M, Lombet A, Perrot JY, Jacob D, Carvajal S, Kazem A, Rostene W, Therwath A, Gompel A 1999 Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol 69:463-471 (Pubitemid 29305570)
33. Lapointe J, Fournier A, Richard V, Labrie C 1999 Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells. Endocrinology 140:416-421 (Pubitemid 29011187)
34. Peters AA, Ingman WV, Tilley WD, Butler LM 2011 Differential effects of exogenous androgen and an androgen receptor antagonist in the peri- and postpubertal murine mammary gland. Endocrinology 152:3728-3737
35. Labrie F 2003 Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris) 64:95-107 (Pubitemid 36565163)
36. Labrie F, Luu-The V, Labrie C, Bélanger A, Simard J, Lin SX, Pelletier G 2003 Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 24:152-182 (Pubitemid 36515283)
37. Geisler J, Lønning PE 2010 Impact of aromatase inhibitors on bone health in breast cancer patients. The Journal of Steroid Biochemistry And Molecular Biology 118:294-299
38. Clarke RB, Howell A, Potten CS, Anderson E 1997 Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987-4991 (Pubitemid 27498105)
39. Gustafsson JA, Warner M 2000 Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J Steroid Biochem Mol Biol 74:245-248 (Pubitemid 32140403)
40. Peters AA, Buchanan G, Ricciardelli C, Bianco-Miotto T, Centenera MM, Harris JM, Jindal S, Segara D, Jia L, Moore NL, Henshall SM, Birrell SN, Coetzee GA, Sutherland RL, Butler LM, Tilley WD 2009 Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer. Cancer Res 69:6131-6140
41. Bentov Y, Casper RF 2008 Sex hormone receptors and testosterone in postmenopausal women. Menopause 15:210-211 (Pubitemid 351354976)